CHICAGO/WASHINGTON (Reuters) – AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters. AstraZeneca’s large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in … Continue reading Exclusive: AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week – sources